Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Kreiter

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Progress in Tumor Research|September 19, 2015
Current Developments in Actively Personalized Cancer Vaccination with a Focus on RNA as the Drug FormatMustafa Diken, Sebastian Kreiter, Björn Kloke, et al.
Current Issues in Molecular Biology|November 2, 2016
mRNA: A Versatile Molecule for Cancer VaccinesMustafa Diken, Lena M Kranz, Sebastian Kreiter, et al.
Oncoimmunology|August 31, 2012
Targeting the tumor mutanome for personalized vaccination therapySebastian Kreiter, John C Castle, Ozlem Türeci, et al.
Current Opinion in Immunology|April 19, 2011
Tumor vaccination using messenger RNA: prospects of a future therapySebastian Kreiter, Mustafa Diken, Abderraouf Selmi, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Antitumor vaccination with synthetic mRNA: strategies for in vitro and in vivo preclinical studiesMustafa Diken, Sebastian Kreiter, Abderraouf Selmi, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 2, 2019
Personalized Neo-Epitope Vaccines for Cancer TreatmentMathias Vormehr, Mustafa Diken, Özlem Türeci, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2016
FLT3 Ligand as a Molecular Adjuvant for Naked RNA VaccinesSebastian Kreiter, Mustafa Diken, Abderraouf Selmi, et al.
Nature Cancer|July 6, 2023
The landscape of T cell antigens for cancer immunotherapyAviyah Peri, Nadja Salomon, Yochai Wolf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2016
Targeting the Heterogeneity of Cancer with Individualized Neoepitope VaccinesÖzlem Türeci, Mathias Vormehr, Mustafa Diken, et al.
Cancer Immunology, Immunotherapy : CII|March 16, 2007
Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNASebastian Kreiter, Thorsten Konrad, Martina Sester, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Progress in Tumor Research|September 19, 2015
Current Developments in Actively Personalized Cancer Vaccination with a Focus on RNA as the Drug FormatMustafa Diken, Sebastian Kreiter, Björn Kloke, et al.
Current Issues in Molecular Biology|November 2, 2016
mRNA: A Versatile Molecule for Cancer VaccinesMustafa Diken, Lena M Kranz, Sebastian Kreiter, et al.
Oncoimmunology|August 31, 2012
Targeting the tumor mutanome for personalized vaccination therapySebastian Kreiter, John C Castle, Ozlem Türeci, et al.
Current Opinion in Immunology|April 19, 2011
Tumor vaccination using messenger RNA: prospects of a future therapySebastian Kreiter, Mustafa Diken, Abderraouf Selmi, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 9, 2013
Antitumor vaccination with synthetic mRNA: strategies for in vitro and in vivo preclinical studiesMustafa Diken, Sebastian Kreiter, Abderraouf Selmi, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 2, 2019
Personalized Neo-Epitope Vaccines for Cancer TreatmentMathias Vormehr, Mustafa Diken, Özlem Türeci, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 30, 2016
FLT3 Ligand as a Molecular Adjuvant for Naked RNA VaccinesSebastian Kreiter, Mustafa Diken, Abderraouf Selmi, et al.
Nature Cancer|July 6, 2023
The landscape of T cell antigens for cancer immunotherapyAviyah Peri, Nadja Salomon, Yochai Wolf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 17, 2016
Targeting the Heterogeneity of Cancer with Individualized Neoepitope VaccinesÖzlem Türeci, Mathias Vormehr, Mustafa Diken, et al.
Cancer Immunology, Immunotherapy : CII|March 16, 2007
Simultaneous ex vivo quantification of antigen-specific CD4+ and CD8+ T cell responses using in vitro transcribed RNASebastian Kreiter, Thorsten Konrad, Martina Sester, et al.
Pageof 6